Trends and De-escalation of Dual Antiplatelet Therapy in Acute MI Patients Undergoing PCI



Dual antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is the standard for ACS patients after PCI. Ticagrelor, introduced in Taiwan in 2013, is first-line for acute MI without high bleeding risk, while clopidogrel remains common in Korea.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our